Advances in Prebiotic and Probiotic Therapies for Disorders of the Gastrointestinal Tract

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This Genetic Technology TOE depicts trends across prebiotic and probiotic therapies for disorders of the gastrointestinal tract. The corresponding analysis of leading prebiotic and probiotic companies, and the analysis of Top 20 companies with OTC prebiotics and probiotics are depicted along with industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular

Table of Contents

Advances in Prebiotic and Probiotic Therapies for Disorders of the Gastrointestinal TractAdvances in Prebiotic and Probiotic Therapy for the Management of GI DiseasesLeveraging Bacterial Strains to Treat Inflammatory Bowel DiseaseNovel Prebiotic Technology for Management of Lactose IntoleranceLeveraging Lactobacillus for Diarrhea ManagementYeasts for Enhancing Intestinal HealthAnalysis of Leading Prebiotic and Probiotic Companies and Industry InteractionsAnalysis of Top 20 Companies with OTC Prebiotics and ProbioticsIndustry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.